Osteosarcopenia and TAVR Outcomes

This chapter explores the impact of osteosarcopenia on mortality rates among older patients undergoing transcatheter aortic valve replacement (TAVR). It emphasizes the necessity of a comprehensive assessment of muscle and bone health, along with interventions such as exercise therapy and nutrition to improve patient outcomes. The discussion includes advancements in screening processes and the role of AI tools in evaluating frailty in this patient demographic.